Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
Injection site warmth Reports for DTaP
#6 most reported symptom for this vaccine
Injection site warmth and DTaP
Injection site warmth has been reported 5,634 times in association with DTaP vaccination in VAERS. This represents 8.4% of all 66,714 reports for this vaccine.
Among these reports, 0 mentioned death (0.00%) and 86 involved hospitalization (1.5%).
Injection site warmth is the #6 most frequently reported symptom for DTaP out of 1943 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
What This Means
Seeing 5,634 reports of Injection site warmth after DTaP vaccination may seem alarming, but context is critical.
The mortality rate among these reports is very low at 0.00%, suggesting most cases are non-fatal.
Important Context
Quick Facts
Related Pages
Data Source
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.